Several new studies and articles have come out recently linked to various treatments for migraine.
CGRP inhibitors are a breakthrough in migraine treatment. A new type of CGRP inhibitor, Atogepant, has been approved for use. A recent study found that Atogepant resulted in greater improvements in efficacy and quality of life in comparison with Rimegepant, with comparable safety profiles. However, only Rimegepant is currently available in Wales for both acute and preventative use. Read about the study, or read the scientific article.
However, CGRP is just one migraine pathway, and this recent article explains that CGRP inhibitors don’t work for everyone. Prof. Anne Magregor also has an article on the complexities of Migraine and menopause.
However, CGRP is not the only peptite that might be linked to migraines. Dr. Mesoud Ashina talked on the Spotlinght on Migraine podcast about PACAP, how it differs from CGRP, and its potential as a target for migraine. Listen to the podcast.
But the physical aspects of migraine are just one part of the condition. Chloe Fudge, a master’s student in psychology at the University of Lincoln, is conducting research on the relationship between chronic migraine, depression, and social support. She is being supervised by Dr Susan Chipchase who studies memory, healthcare and chronic illness. You can help them by taking their anonymous 15-minute survey about your experiences.
Finally, although there is limited scientific evidence that cold therapy can prevent migraines, some of our members have been enjoying ice bath and cold contrast therapy at Tanarhew.
Migraine Cymru Wales 
Leave a comment